New FDA documents show internal dissent on Aduhelm approval
In a lengthy review document and a pair of memos from top officials, the FDA released on Tuesday night its most detailed argument yet for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
